Page 1 of Clinical Trials for Dimebon, 27 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin
Last Updated: February 2, 2010
Condition(s): Alzheimer's Disease; Huntington's Disease
2
Completed
A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Last Updated: July 24, 2008
Condition(s): Huntington's Disease
3
Completed
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
Last Updated: April 20, 2009
Condition(s): Alzheimer's Disease; Huntington's Disease
4
Completed
A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers
Last Updated: November 17, 2009
Condition(s): Alzheimer's Disease; Huntington's Disease
5
Completed
A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
Last Updated: April 13, 2011
Condition(s): Huntington Disease
6
Active, not recruiting
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Last Updated: July 14, 2009
Condition(s): Alzheimer's Disease
7
Completed
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
Last Updated: September 14, 2009
Condition(s): Hepatic Failure
8
Completed
A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
Last Updated: April 22, 2011
Condition(s): Alzheimer's Disease; Huntington's Disease
9
Completed
A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)
Last Updated: January 11, 2010
Condition(s): Alzheimer's Disease; Huntington Disease
10
Completed
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
Last Updated: December 29, 2009
Condition(s): Alzheimer's Disease; Huntington's Disease
11
Completed
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
Last Updated: February 25, 2010
Condition(s): Alzheimer's Disease; Huntington's Disease
12
Completed
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Last Updated: April 5, 2011
Condition(s): Alzheimer's Disease
13
Completed
A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults
Last Updated: July 20, 2009
Condition(s): Healthy Volunteers
14
Completed
Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
Last Updated: June 9, 2009
Condition(s): Alzheimer Disease; Huntington Disease
15
Withdrawn
A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
Last Updated: June 28, 2010
Condition(s): Alzheimer's Disease; Dementia; Dimebon; Investigational Drug
16
Active, not recruiting
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
Last Updated: April 14, 2009
Condition(s): Alzheimer's Disease
17
Completed
An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Last Updated: March 5, 2012
Condition(s): Huntington Disease
18
Terminated
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Last Updated: September 8, 2011
Condition(s): Alzheimer Disease
19
Completed
Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Last Updated: January 3, 2008
Condition(s): Huntington's Disease
20
Terminated
A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: May 14, 2010
Condition(s): Moderate to Severe Alzheimer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Dimebon

Page 1 of Clinical Trials for Dimebon, 27 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About